Multiple dosing of long-acting rilpivirine in a model of HIV pre-exposure prophylaxis
A long-acting antiretroviral agent such as rilpivirine could further improve pre-exposure prophylaxis (PrEP), already shown to be safe and effective at preventing AIDS in high risk populations, as it could overcome problems ...
Jul 25, 2019
0
0